Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

89.51 USD +1.42 (+1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 705,824
Open 88.69
Bid (Size) 89.00 (25)
Ask (Size) 89.99 (2)
Prev. Close 88.09
Today's Range 88.48 - 90.41
52wk Range 32.86 - 93.66
Shares Outstanding 104,084,876
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress
Arrowhead presents data at EASL showing ARO-HSD reduces HSD17B13 mRNA and protein in the liver leading to reductions in ALT 
From Business Wire News Releases
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) and Horizon Therapeutics plc (NASDAQ: HZNP) today announced a global collaboration and license agreement for ARO-XDH, a previously undisclosed... 
From Business Wire News Releases

Performance

YTD
+19.62%
+19.62%
1 Month
+21.17%
+21.17%
3 Month
+37.26%
+37.26%
6 Month
+6.32%
+6.32%
1 Year
+125.13%
+125.13%

More News

Read More
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
From Business Wire News Releases
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-APOC3 for Treatment of Severe Hypertriglyceridemia
From Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences
From Business Wire News Releases
Horizon Acquires Rights to Arrowhead's RNAi-Based Gout Treatment Candidate
Tags HZNP General Benzinga
From Benzinga
First Week of August 20th Options Trading For Arrowhead Pharmaceuticals (ARWR)
Tags Stocks
From Market News Video
Arrowhead Earns $10 Million Option Exercise Fee
From Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences
From Business Wire News Releases
The Week In Charts - Why You Can't Trade, Or Maybe You Can?
Tags Stocks / Equities Market News ETFs
From Blogs - TalkMarkets
Is this the Manchin rally? Bonds are rising and stocks at record high as spending expectations wane
Tags NQ00 BX:TMUBMUSD10Y AMZN
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.